Saro Khemichian
PERSONAL INFORMATION:
Work
1510 San Pablo St.
Los Angeles, CA 90033
Home
4322 Bel Aire Dr.
La Canada, CA 91011
Citizenship: United States
Phone: 818-400-4282
Fax: 323-442-6169
Work Email: khemichi@usc.edu
EDUCATION:
1992 - Diploma, Hoover High School, Glendale CA
1997 - BS, Biochemistry, Univedrsity of California, Los Angeles
1999 - MS, Physiology, Georgetown University, Wahsingotn D.C.
2003 - MD, University of Southern Califronia, Los Angeles
POST-GRADUATE TRAINING:
2004 - Internship, Internal Medicine, LAC-USC Medical Center, Los Angeles
2006 - Residency, Internal Medicine, LAC-USC Medical Center. Los Angeles
2010 - Fellowship, Gastroenterology/Liver, LAC-USC Medical Center, Los Angeles
2011 - Fellowship, Transplant Hepatology, Keck Medical Center of USC, Los Angeles
ACADEMIC AND CLINICAL APPOINTMENTS:
2012 - Assistant Professor of Clinical Medicine, Medicine, division of GI/Liver Keck School of Medicine of USC, Los Angeles, CA
LICENSURE:
2/2/2005 - A90035, California, Active
BOARD CERTIFICATION OR ELIGIBILITY:
2010 - Gastroenterology
SPECIALTY CERTIFICATION:
2012 - Transplant Hepatology
HONORS, AWARDS:
1998 - Woodbadge Scouting Award, Boy Scouts of America
2004 - Intern of the Year, USC Internal Medicine
SERVICE
DEPARTMENT SERVICE:
2013-Current - Member of GI fellowship Clinical Competency Committee, Division of GI/Liver
2013-2019 - Member Practice Operations and Development Committee, Department of Medicine
2004-2010 - Member Internal Medicine Resident Perofrmance Review Committee, Department of Medicine
HOSPITAL OR MEDICAL GROUP SERVICE:
2021 - Volunteered and helped with Keck COVID Vaccination process, Keck Hospital
2020 - Member of the Keck hospital "Care Delivery Re-design" committee for the transplant program, Keck Hospital
2020-2021 - Member of the COVID solid organ transplant task force, Keck Hospital
2020-2021 - Review of cases for office of quality and outcome management, Keck Hospital
2020-2021 - Physician Templates and Scheduling Guidelines (Protocols), Keck Hospital
2019-Curren- Member of United Network for Organ Sharing HCC Review Board Keck Hospital, Keck Hospital/Liver transplant
PROFESSIONAL SERVICE:
2022 - Global Outreach and Engagement Committee, American Association for Study of Liver DIseases
PROFESSIONAL SOCIETY MEMBERSHIPS:
2012-Present - American Association for Study of Liver Disease
COMMUNITY SERVICE:
2003-Present - Troop Leader, Boy Scouts of America/Glendale, CA, Troop Leader
2000-2005 - Outreach Representative, Keck School of Medicine, Teaching at Juvenile Hall
MAJOR LEADERSHIP POSITIONS: (E.G., DEAN, CHAIR, INSTITUTE DIRECTOR, HOSPITAL ADMINISTRATION, ETC.)
2020-Current - Associate Medical Director, Associate Medical Director for Liver Transplant Program
TEACHING
DIDACTIC TEACHING:
Institution Keck School of Medicine
Involved in medical student, resident, and fellows academic teaching since 2011.
Presentations have included topics regarding chronic liver disease and viral hepatitis
Other Institution Presentation
2012 - Hepatology Symposium, 1 Units/Hrs, Lecturer at UC Irvine Symposium
2015 - NAFLD-New Developments, Lecturer for Armenian Amedican Medical Association
2017 - HCV Update, 1 Units/Hrs, Lecturer at UC Irvine Symposium
2018 - HCV Update, 1 Units/Hrs, Lecturer at Armenian International Medical World Congress, Yerevan, Armenia
2021 - Primary Care Management of Liver cirrhosis, 1 Units/Hrs, Lecturer for Project ECHO
CME COURSES DEVELOPED
Institution
2014 - HCV Update 1 Units/Hrs, Lecturer in Las Vegas
MAJOR AREAS OF RESEARCH INTEREST
Research Areas
1.Liver cirrhosis and portal hypertension
2. Viral hepatitis
2. Cholestatic diseases of the liver
3. Metabolic diseases of the liver
4. Hepatorenal syndrome
PUBLICATIONS:
REFEREED JOURNAL ARTICLES
1. Khemichian S, Francoz C, Durand F, Karvellas CJ, Nadim MK. Hepatorenal Syndrome. Crit Care Clin 37(2):321-334, 2021. PMID 33752858
2. Patel AA, Ryan GW, Tisnado D, Chuang E, Walling AM, Saab S, Khemichian S, Sundaram V, Brook RH, Wnger NS. Deficits in Advance Care Planning for Patients With Decompensated Cirrhosis at Liver Transplant Centers. JAMA Intern Med 181(5):652-660, 2021. PMID 33720273.
3. Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Eur J Gastroenterol Hepatol 33(4):541-546, 2021. PMID 32398491
4. Olimpiadi YB, Brownson KB, Kahn JA, Kim B, Han H, Khemichian S, Fong TL, Kang I, Terando A, Lang JE. Treatment and Outcomes of Early-Stage Breast Cancer in Patients with Hepatic Dysfunction. J Surg Res. 256:212-219, 2020. PMID 32711178
5. Khemichian S, Terrault NA. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease. Semin Thromb Hemost 46(6):682-692, 2020. PMID 32820479
6. Durand F, Francoz C, Asrani SK, Khemichian S, Pham TA, Sung RS, Genyk YS, Nadim MK. Acute Kidney Injury After Liver Transplantation. Transplantation 102(10):1636-1649, 2018. PMID 29847502
7. Kwo P, Fried MW, Reddy KR, Soldevila-Pico C, Khemichian S, Darling J, Zamor PJ, Napoli AA, Anduze-Faris B, Brown RS Jr. Daclatasvir and Sofosbuvir Treatment of Decompensated Liver Disease or Post-Liver Transplant Hepatitis C Virus Recurrence in Patients With Advanced Liver Disease/Cirrhosis in a Real-World Cohort. Hepatol Commun 2(4):354-363, 2018. PMID 29619415
8. Khemichian S, Lee B, Kahn J, Noureddin M, Kim B, Harper T, Esmailian Y, Fong TL. Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation. Transplantation Direct 1(6):1-5, 2015. PMID 27500223
9. Sheibani S, Khemichian S, Hou LA, Kim JJ, Yan A, Buxbaum JL, Dara L, Laine L. Randomized Trial of 1-week vs. 2-week Intervals for Endoscopic Ligation in the Treatment of Patients with Esophageal Variceal Bleeding. Hepatology 64(2):549-55, 2016. PMID 27082942
10. Zhu J, Khemichian S, Nghiem D, Zhang SR, Limurti J, Saito T, Redeker AG, Fong TL. Comparison of Demographic and Clinical Characteristics of Hispanic and Asian Chronic Hepatitis B patients in Southern California. J Clin Gastroenterol 50(7):602-7, 2016. PMID 26890328
11. Khemichian S, Hsieh MJ, Zhang SR, Limurti J, Kim J, Fong TL. Nucleoside-Nucleotide Analog Combination Therapy is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation. Dig Dis Sci 60(9):2807-12, 2015. PMID 25939541
12. Fong TL, Khemichian S, Shah T, Hutchinson IV, Cho YW. Combined liver kidney transplant is preferable to liver transplant alone for cirrhotic patients with renal failure. Transplantation 94(4):411-16, 2012. PMID 22805440
13. Khemichian S, Fong TL. Hepatic Dysfunction in Hyperthyroidism. Gastroenterol Hepatol 7(5):337-9, 2011. PMID 21857837
14. Khemichian S, Bemanian S. Pulmonary Leiomyosarcoma. Internal Medicine Journal 36(12):793-4, 2006. PMID 17096743
Non-referred Journal Articles
Khemichian S, Fong TL. Hepatitis B and Liver Transplantation. AME Med J 3(3):1-7, 2018.
Book Chapters
1. Francoz C, Durand F, Haddad Z, Hamiduzzaman K, Khemichian S, Maw TT, Genyk Y, Nadim MK. Renal Dysfunction in Patients with Cirrhosis. In: Rahimi R. (eds) The Critically Ill Cirrhotic Patient. Springer, Cham;2020:67-90.
2. Bonthala N, Khemichian S. The Approach to Abnormal Liver Tests. In: Esrailian E, ed. Tarascon Gastroenterology Pocketbook. Jones and Bartlet Learning; 191-196, 2015.
3. Bonthala N, Khemichian S. Primary Sclerosing Cholangitis. In: Esrailian E, ed. Tarascon Gastroenterology Pocketbook. Jones and Bartlet Learning; 225-227, 2015.
4. Khemichian S, Donovan JA. Alcoholic Liver Disease. In: Esrailian E, ed. Gut Instincts: A Clinician’s Handbook of Digestive and Liver Diseases. Slack Incorporated; 251-256, 2012.